On October 30, 2023, the board of directors of BioCorRx Inc. (the ?Company?) approved Brady Granier?s request for a paid administrative leave of absence from his position as the President of the Company for the period between October 30, 2023 and January 30, 2024. Mr. Granier will remain a member of the Board during this period. Effective as of October 30, 2023, Lourdes Felix, the Company?s Chief Executive Officer and Chief Financial Officer, assumed Mr. Granier?s responsibilities during his paid administrative leave of absence.

Ms. Felix?s compensation remains unchanged.